Skip to main content

Table 3 Dose-limiting toxicity

From: Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-

n = 9

Level 1

Level 2**

Level 3*

Hematological toxicity

0

0

0

Nonhematological toxicity

0

0

2

Treatment delay

0

0

0

  1. *: Maximum tolerated dose, **: Recommended dose.